{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:16:20Z","timestamp":1790709380195,"version":"4.1.0"},"reference-count":108,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T00:00:00Z","timestamp":1560902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Neurosci."],"DOI":"10.3389\/fnmol.2019.00156","type":"journal-article","created":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T10:28:47Z","timestamp":1560940127000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":34,"title":["The Emerging Role of microRNAs in Polyglutamine Diseases"],"prefix":"10.3389","volume":"12","author":[{"given":"Xiaoyu","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyan","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,6,19]]},"reference":[{"key":"B456","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1750-1172-6-35","article-title":"Machado-Joseph Disease: from first descriptions to new perspectives","volume":"6","author":"Bettencourt","year":"2011","journal-title":"Orphanet J. Rare Dis."},{"key":"B1","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1007\/s00018-014-1671-7","article-title":"MicroRNA-132,-134, and -138: a microRNA troika rules in neuronal dendrites","volume":"71","author":"Bicker","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"B2","first-page":"434","article-title":"In vivo knock-down of multidrug resistance transporters ABCC1 and ABCC2 by AAV-delivered shRNAs and by artificial miRNAs","volume":"7","author":"Borel","year":"2011","journal-title":"J. RNAi Gene Silencing"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-019-1480-y","article-title":"Wide profiling of circulating MicroRNAs in spinocerebellar ataxia type 7","author":"Borgonio-Cuadra","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/mt.2009.17","article-title":"Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington\u2019s disease mice","volume":"17","author":"Boudreau","year":"2009","journal-title":"Mol. Ther."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.ymthe.2017.01.021","article-title":"Unravelling endogenous microRNA system dysfunction as a new pathophysiological mechanism in Machado-Joseph disease","volume":"25","author":"Carmona","year":"2017","journal-title":"Mol. Ther."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1038\/mt.2011.201","article-title":"Potent and selective antisense oligonucleotides targeting single-nucleotide polymorphisms in the huntington disease gene\/allele-specific silencing of mutant huntingtin","volume":"19","author":"Carroll","year":"2011","journal-title":"Mol. Ther."},{"key":"B7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s13023-017-0742-x","article-title":"Down-regulation of miR-9*in the peripheral leukocytes of Huntington\u2019s disease patients","volume":"12","author":"Chang","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/dvdy.24240","article-title":"Developmental insights into the pathology of and therapeutic strategies for DM1: back to the basics","volume":"244","author":"Chau","year":"2015","journal-title":"Dev. Dyn."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1159\/000491543","article-title":"The role of MiR-132 in regulating neural stem cell proliferation, differentiation and neuronal maturation","volume":"47","author":"Chen","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"B11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.tcb.2011.12.001","article-title":"Secreted microRNAs: a new form of intercellular communication","volume":"22","author":"Chen","year":"2012","journal-title":"Trends Cell Biol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e3014","DOI":"10.1002\/jgm.3014","article-title":"MicroRNA expression data analysis to identify key miRNAs associated with Alzheimer\u2019s disease","volume":"20","author":"Chen","year":"2018","journal-title":"J. Gene Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nn.2294","article-title":"miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche","volume":"12","author":"Cheng","year":"2009","journal-title":"Nat. Neurosci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1073\/pnas.0511041103","article-title":"Reciprocal actions of REST and a microRNA promote neuronal identity","volume":"103","author":"Conaco","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1038\/mt.2013.144","article-title":"Toward RNAi therapy for the polyglutamine disease Machado-Joseph disease","volume":"21","author":"Costa","year":"2013","journal-title":"Mol. Ther."},{"key":"B15","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s12311-016-0794-9","article-title":"Mutant Ataxin-1 inhibits neural progenitor cell proliferation in SCA1","volume":"16","author":"Cvetanovic","year":"2017","journal-title":"Cerebellum"},{"key":"B16","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.bbrc.2013.06.041","article-title":"MicroRNA-124 targets CCNA2 and regulates cell cycle in STHdh(Q121)\/Hdh(Q121) cells","volume":"437","author":"Das","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/ng0997-65","article-title":"Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion","volume":"17","author":"David","year":"1997","journal-title":"Nat. Genet."},{"key":"B18","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.phrs.2016.05.005","article-title":"Circulating microRNAs in Huntington\u2019s disease: emerging mediators in metabolic impairment","volume":"108","author":"D\u00edez-Planelles","year":"2016","journal-title":"Pharmacol. Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/s1474-4422(10)70183-6","article-title":"Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond","volume":"9","author":"Durr","year":"2010","journal-title":"Lancet Neurol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3389\/fphys.2015.00040","article-title":"The emerging role of microRNAs in Alzheimer\u2019s disease","volume":"6","author":"Femminella","year":"2015","journal-title":"Front. Physiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nrg2290","article-title":"Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?","volume":"9","author":"Filipowicz","year":"2008","journal-title":"Nat. Rev. Genet."},{"key":"B22","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s12311-008-0027-y","article-title":"Molecular pathogenesis and cellular pathology of spinocerebellar ataxia type 7 neurodegeneration","volume":"7","author":"Garden","year":"2008","journal-title":"Cerebellum"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1093\/hmg\/ddr111","article-title":"Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington\u2019s disease","volume":"20","author":"Gaughwin","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"B24","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.bbrc.2018.06.034","article-title":"\u03b2 catenin is regulated by its subcellular distribution and mutant huntingtin status in Huntington\u2019s disease cell STHdhQ111\/HdhQ111","volume":"503","author":"Ghatak","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B25","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3389\/fncel.2013.00178","article-title":"Neuronal dark matter: the emerging role of microRNAs in neurodegeneration","volume":"7","author":"Goodall","year":"2013","journal-title":"Front. Cell. Neurosci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1016\/j.bbadis.2018.04.012","article-title":"Targeted biochemical profiling of brain from Huntington\u2019s disease patients reveals novel metabolic pathways of interest","volume":"1864","author":"Graham","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/aps.2018.11","article-title":"Proteostasis in Huntington\u2019s disease: disease mechanisms and therapeutic opportunities","volume":"39","author":"Harding","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"B28","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s12264-010-0113-2","article-title":"Current understanding on the pathogenesis of polyglutamine diseases","volume":"26","author":"He","year":"2010","journal-title":"Neurosci. Bull."},{"key":"B29","doi-asserted-by":"publisher","first-page":"R83","DOI":"10.1093\/hmg\/ddx261","article-title":"Genetic modifiers of Mendelian disease: huntington\u2019s disease and the trinucleotide repeat disorders","volume":"26","author":"Holmans","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e1004188","DOI":"10.1371\/journal.pgen.1004188","article-title":"MicroRNAs located in the Hox gene clusters are implicated in huntington\u2019s disease pathogenesis","volume":"10","author":"Hoss","year":"2014","journal-title":"PLoS Genet."},{"key":"B31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12920-015-0083-3","article-title":"miR-10b-5p expression in Huntington\u2019s disease brain relates to age of onset and the extent of striatal involvement","volume":"8","author":"Hoss","year":"","journal-title":"BMC Med. Genomics"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1002\/mds.26457","article-title":"Study of plasma-derived miRNAs mimic differences in huntington\u2019s disease brain","volume":"30","author":"Hoss","year":"","journal-title":"Mov. Disord."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.chembiol.2010.10.013","article-title":"Allele-selective inhibition of huntingtin expression by switching to an miRNA-like RNAi mechanism","volume":"17","author":"Hu","year":"2010","journal-title":"Chem. Biol."},{"key":"B35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-1-4939-7046-9_4","article-title":"MicroRNAs: biomarkers, diagnostics, and therapeutics","volume-title":"Bioinformatics in MicroRNA Research","author":"Huang","year":"2017"},{"key":"B36","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1134\/s1068162010060026","article-title":"Biological functions of microRNAs","volume":"36","author":"Huang","year":"2010","journal-title":"Bioorg. Khim."},{"key":"B34","doi-asserted-by":"publisher","first-page":"4791","DOI":"10.1016\/j.febslet.2014.11.013","article-title":"miR-25 alleviates polyQ-mediated cytotoxicity by silencing ATXN3","volume":"588","author":"Huang","year":"2014","journal-title":"FEBS Lett."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1093\/hmg\/ddq063","article-title":"An ovine transgenic Huntington\u2019s disease model","volume":"19","author":"Jacobsen","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"B38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ejphar.2015.10.033","article-title":"Antidepressants for neuroprotection in huntington\u2019s disease: a review","volume":"769","author":"Jamwal","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12017-009-8063-4","article-title":"Gene dysregulation in huntington\u2019s disease: REST, microRNAs and beyond","volume":"11","author":"Johnson","year":"2009","journal-title":"Neuromolecular Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.nbd.2007.11.001","article-title":"A microRNA-based gene dysregulation pathway in huntington\u2019s disease","volume":"29","author":"Johnson","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e54222","DOI":"10.1371\/journal.pone.0054222","article-title":"MicroRNA-22 (miR-22) overexpression is neuroprotective via general anti-apoptotic effects and may also target specific huntington\u2019s disease-related mechanisms","volume":"8","author":"Jovicic","year":"2013","journal-title":"PLoS One"},{"key":"B44","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.cell.2007.09.020","article-title":"The conserved microRNA miR-8 tunes atrophin levels to prevent neurodegeneration in Drosophila","volume":"131","author":"Karres","year":"2007","journal-title":"Cell"},{"key":"B45","doi-asserted-by":"publisher","first-page":"R53","DOI":"10.1093\/hmg\/ddv442","article-title":"Gene suppression strategies for dominantly inherited neurodegenerative diseases: lessons from huntington\u2019s disease and spinocerebellar ataxia","volume":"25","author":"Keiser","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1038\/nn2010","article-title":"Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA","volume":"10","author":"Klein","year":"2007","journal-title":"Nat. Neurosci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1756-6606-7-46","article-title":"microRNA-128a dysregulation in transgenic huntington\u2019s disease monkeys","volume":"7","author":"Kocerha","year":"2014","journal-title":"Mol. Brain"},{"key":"B48","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/2053-8871-1-7","article-title":"Current understanding of the role of microRNAs in spinocerebellar ataxias","volume":"1","author":"Koscianska","year":"2014","journal-title":"Cerebellum Ataxias"},{"key":"B50","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/bs.pmbts.2016.12.013","article-title":"MicroRNAs as peripheral biomarkers in aging and age-related diseases","volume":"146","author":"Kumar","year":"2017","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e0162788","DOI":"10.1371\/journal.pone.0162788","article-title":"miR-196a ameliorates cytotoxicity and cellular phenotype in transgenic Huntington\u2019s disease monkey neural cells","volume":"11","author":"Kunkanjanawan","year":"2016","journal-title":"PLoS One"},{"key":"B52","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/352077a0","article-title":"Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy","volume":"352","author":"La Spada","year":"1991","journal-title":"Nature"},{"key":"B53","doi-asserted-by":"publisher","first-page":"e0190550","DOI":"10.1371\/journal.pone.0190550","article-title":"MicroRNA signatures of endogenous Huntingtin CAG repeat expansion in mice","volume":"13","author":"Langfelder","year":"2018","journal-title":"PLoS One"},{"key":"B54","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.neuint.2018.04.015","article-title":"Huntington\u2019s disease pattern of transcriptional dysregulation in the absence of mutant huntingtin is produced by knockout of neuronal GLT-1","volume":"123","author":"Laprairie","year":"2019","journal-title":"Neurochem. Int."},{"key":"B55","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.semcdb.2010.01.009","article-title":"Dysregulated microRNAs in neurodegenerative disorders","volume":"21","author":"Lau","year":"2010","journal-title":"Semin Cell Dev. Biol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/nn.2183","article-title":"miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis","volume":"11","author":"Lee","year":"2008","journal-title":"Nat. Neurosci."},{"key":"B57","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","article-title":"Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets","volume":"120","author":"Lewis","year":"2005","journal-title":"Cell"},{"key":"B58","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s10549-018-4757-3","article-title":"Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer","volume":"170","author":"Li","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"key":"B60","doi-asserted-by":"publisher","first-page":"786","DOI":"10.4103\/1673-5374.156978","article-title":"MicroRNA-124 slows down the progression of Huntington\u2019s disease by promoting neurogenesis in the striatum","volume":"10","author":"Liu","year":"2015","journal-title":"Neural Regen. Res."},{"key":"B59","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2217\/epi-2017-0089","article-title":"Epigenetic profiles in polyglutamine disorders","volume":"10","author":"Liu","year":"2018","journal-title":"Epigenomics"},{"key":"B61","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.molcel.2007.07.015","article-title":"The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative Pre-mRNA splicing","volume":"27","author":"Makeyev","year":"2007","journal-title":"Mol. Cell"},{"key":"B62","doi-asserted-by":"publisher","first-page":"7219","DOI":"10.1093\/nar\/gkq575","article-title":"A myriad of miRNA variants in control and Huntington\u2019s disease brain regions detected by massively parallel sequencing","volume":"38","author":"Mart\u00ed","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"B63","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/s0022-510x(99)00176-8","article-title":"Spinocerebellar ataxia type 7 (SCA7)\u2014correlations between phenotype and genotype in one large Belgian family","volume":"168","author":"Martin","year":"1999","journal-title":"J. Neurol. Sci."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1126\/science.1146067","article-title":"MicroRNA inhibition of translation initiation in vitro by targeting the cap-binding complex elF4F","volume":"317","author":"Mathonnet","year":"2007","journal-title":"Science"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1038\/mt.2011.219","article-title":"Preclinical safety of RNAi-mediated HTT suppression in the rhesus macaque as a potential therapy for Huntington\u2019s disease","volume":"19","author":"McBride","year":"2011","journal-title":"Mol. Ther."},{"key":"B66","doi-asserted-by":"publisher","first-page":"E655","DOI":"10.1073\/pnas.1107198108","article-title":"The Ataxin-2 protein is required for microRNA function and synapse-specific long-term olfactory habituation","volume":"108","author":"McCann","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jnr.22701","article-title":"Role of microRNAs in central nervous system development and pathology","volume":"90","author":"Meza-Sosa","year":"2012","journal-title":"J. Neurosci. Res."},{"key":"B68","doi-asserted-by":"publisher","first-page":"e297","DOI":"10.1038\/mtna.2016.7","article-title":"Design, characterization, and lead selection of therapeutic miRNAs targeting huntingtin for development of gene therapy for Huntington\u2019s disease","volume":"5","author":"Miniarikova","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1038\/nm.2791","article-title":"Viral delivery of miR-196a ameliorates the SBMA phenotype via the silencing of CELF2","volume":"18","author":"Miyazaki","year":"2012","journal-title":"Nat. Med."},{"key":"B70","doi-asserted-by":"publisher","first-page":"347ra394","DOI":"10.1126\/scitranslmed.aaf5660","article-title":"An miRNA-mediated therapy for SCA6 blocks IRES-driven translation of the CACNA1A second cistron","volume":"8","author":"Miyazaki","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"B72","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3389\/fneur.2013.00127","article-title":"Multiple aspects of gene dysregulation Huntington\u2019s disease","volume":"4","author":"Moumn\u00e9","year":"2013","journal-title":"Front. Neurol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"2316.e17","DOI":"10.1016\/j.neurobiolaging.2010.03.014","article-title":"Genome-wide analysis of miRNA expression reveals a potential role for miR-144 in brain aging and spinocerebellar ataxia pathogenesis","volume":"32","author":"Persengiev","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"B75","doi-asserted-by":"publisher","first-page":"e55724","DOI":"10.3791\/55724","article-title":"Systemic delivery of MicroRNA using recombinant adeno-associated virus serotype 9 to treat neuromuscular diseases in rodents","volume":"138","author":"Pourshafie","year":"2018","journal-title":"J. Vis. Exp."},{"key":"B74","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/mt.2016.13","article-title":"MiR-298 counteracts mutant androgen receptor toxicity in spinal and bulbar muscular atrophy","volume":"24","author":"Pourshafie","year":"2016","journal-title":"Mol. Ther."},{"key":"B76","doi-asserted-by":"publisher","first-page":"e95362","DOI":"10.1371\/journal.pone.0095362","article-title":"RNA interference-based therapy for spinocerebellar ataxia type 7 retinal degeneration","volume":"9","author":"Ramachandran","year":"","journal-title":"PLoS One"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1038\/mt.2014.108","article-title":"Nonallele specific silencing of ataxin-7 improves disease phenotypes in a mouse model of SCA7","volume":"22","author":"Ramachandran","year":"","journal-title":"Mol. Ther."},{"key":"B78","doi-asserted-by":"publisher","first-page":"E264","DOI":"10.1212\/wnl.0000000000004844","article-title":"MicroRNAs in CSF as prodromal biomarkers for Huntington disease in the PREDICT-HD study","volume":"90","author":"Reed","year":"2018","journal-title":"Neurology"},{"key":"B79","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2174\/1566523218666180119120726","article-title":"Neurodegenerative disorders treatment: the MicroRNA role","volume":"17","author":"Ridolfi","year":"2017","journal-title":"Curr. Gene Ther."},{"key":"B80","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/978-1-4939-6539-7_13","article-title":"microRNA target prediction","volume-title":"Cancer Gene Networks","author":"Ritchie","year":"2017"},{"key":"B81","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/mt.2013.152","article-title":"Silencing mutant ATXN3 expression resolves molecular phenotypes in SCA3 transgenic mice (vol 21, pg 1909, 2013)","volume":"22","author":"Rodr\u00edguez-Lebr\u00f3n","year":"2014","journal-title":"Mol. Ther."},{"key":"B82","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.nbd.2013.01.019","article-title":"Altered Purkinje cell miRNA expression and SCA1 pathogenesis","volume":"54","author":"Rodriguez-Lebron","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"B83","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12974-017-0925-3","article-title":"microRNA dysregulation in polyglutamine toxicity of TATA-box binding protein is mediated through STAT1 in mouse neuronal cells","volume":"14","author":"Roshan","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"B84","doi-asserted-by":"publisher","first-page":"891","DOI":"10.4161\/rna.19876","article-title":"Regulation of BACE1 by miR-29a\/b in a cellular model of spinocerebellar ataxia 17","volume":"9","author":"Roshan","year":"2012","journal-title":"RNA Biol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1261\/rna.044008.113","article-title":"Brain-specific knockdown of miR-29 results in neuronal cell death and ataxia in mice","volume":"20","author":"Roshan","year":"2014","journal-title":"RNA"},{"key":"B86","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.bcp.2017.07.008","article-title":"MicroRNA: basic concepts and implications for regeneration and repair of neurodegenerative diseases","volume":"141","author":"Saraiva","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"e22231","DOI":"10.1371\/journal.pone.0022231","article-title":"Decreased striatal RGS2 expression is neuroprotective in Huntington\u2019s disease (HD) and exemplifies a compensatory aspect of HD-induced gene regulation","volume":"6","author":"Seredenina","year":"2011","journal-title":"PLoS One"},{"key":"B88","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3389\/fnagi.2018.00139","article-title":"Regulation of MicroRNAs-mediated autophagic flux: a new regulatory avenue for neurodegenerative diseases with focus on prion diseases","volume":"10","author":"Shah","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"B90","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3109\/00207454.2013.827679","article-title":"MicroRNA profiling in the serums of SCA3\/MJD patients","volume":"124","author":"Shi","year":"2014","journal-title":"Int. J. Neurosci."},{"key":"B91","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.bbrc.2010.05.007","article-title":"Altered microRNAs in STHdh(Q121)\/Hdh(Q121) cells: miR-146a targets TBP","volume":"396","author":"Sinha","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B92","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/jcb.26209","article-title":"Simulation based investigation of deleterious nsSNPs in ATXN2 gene and its structural consequence toward spinocerebellar ataxia","volume":"119","author":"Sinha","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"B93","doi-asserted-by":"publisher","first-page":"e0182629","DOI":"10.1371\/journal.pone.0182629","article-title":"The use of high-throughput small RNA sequencing reveals differentially expressed microRNAs in response to aster yellows phytoplasma-infection in Vitis vinifera cv. \u2018Chardonnay\u2019","volume":"12","author":"Snyman","year":"2017","journal-title":"PLoS One"},{"key":"B94","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/jnc.12090","article-title":"Dysregulation of REST-regulated coding and non-coding RNAs in a cellular model of Huntington\u2019s disease","volume":"124","author":"Soldati","year":"2013","journal-title":"J. Neurochem."},{"key":"B95","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.semcancer.2008.01.005","article-title":"MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation","volume":"18","author":"Sonkoly","year":"2008","journal-title":"Semin. Cancer Biol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1038\/mt.2014.153","article-title":"In vivo evaluation of candidate allele-specific mutant huntingtin gene silencing antisense oligonucleotides","volume":"22","author":"Southwell","year":"2014","journal-title":"Mol. Ther."},{"key":"B97","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.expneurol.2011.11.020","article-title":"Widespread suppression of huntingtin with convection-enhanced delivery of siRNA","volume":"233","author":"Stiles","year":"2012","journal-title":"Exp. Neurol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/nsmb0315-272b","article-title":"Cross-talking noncoding RNAs contribute to cell-specific neurodegeneration in SCA7 (vol 21, pg 955, 2014)","volume":"22","author":"Tan","year":"2015","journal-title":"Nat. Struct. Mol. Biol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s12035-014-8803-9","article-title":"Causes and consequences of MicroRNA dysregulation in neurodegenerative diseases","volume":"51","author":"Tan","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.nbd.2017.08.003","article-title":"Spinocerebellar ataxia: miRNAs expose biological pathways underlying pervasive Purkinje cell degeneration","volume":"108","author":"van der Stijl","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"B101","doi-asserted-by":"publisher","first-page":"4443","DOI":"10.1007\/s00018-014-1628-x","article-title":"miR-1, miR-10b, miR-155, and miR-191 are novel regulators of BDNF","volume":"71","author":"Varendi","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"B102","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1073\/pnas.0508448102","article-title":"A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis (vol 102, pg 16426, 2005)","volume":"103","author":"Vo","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B103","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/978-1-62703-971-0_27","article-title":"MicroRNA-mediated deadenylation in a mammalian cell-free system","volume-title":"Polyadenylation: Methods and Protocols","author":"Wakiyama","year":"2014"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1373\/clinchem.2010.147405","article-title":"The MicroRNA spectrum in 12 body fluids","volume":"56","author":"Weber","year":"2010","journal-title":"Clin. Chem."},{"key":"B106","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fnmol.2016.00129","article-title":"Getting miRNA therapeutics into the target cells for neurodegenerative diseases: a mini-review","volume":"9","author":"Wen","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"B107","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/ncb0309-228","article-title":"Many roads to maturity: microRNA biogenesis pathways and their regulation","volume":"11","author":"Winter","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"755","DOI":"10.3233\/JAD-150619","article-title":"Circulating microRNAs as biomarkers of Alzheimer\u2019s disease: a systematic review","volume":"49","author":"Wu","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"B109","doi-asserted-by":"publisher","first-page":"R85","DOI":"10.1186\/gb-2006-7-9-r85","article-title":"Comparative sequence analysis reveals an intricate network among REST, CREB and miRNA in mediating neuronal gene expression","volume":"7","author":"Wu","year":"2006","journal-title":"Genome Biol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1111\/j.1742-4658.2010.07594.x","article-title":"An estrogen receptor \u03b1 suppressor, microRNA-22, is downregulated in estrogen receptor \u03b1-positive human breast cancer cell lines and clinical samples","volume":"277","author":"Xiong","year":"2010","journal-title":"FEBS J."},{"key":"B111","doi-asserted-by":"publisher","first-page":"11992","DOI":"10.1038\/srep11992","article-title":"Primary microRNA processing is functionally coupled to RNAP II transcription in vitro","volume":"5","author":"Yin","year":"2015","journal-title":"Sci. Rep."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1016\/j.bpj.2018.02.037","article-title":"Insights into the aggregation mechanism of PolyQ proteins with different glutamine repeat lengths","volume":"114","author":"Yushchenko","year":"2018","journal-title":"Biophys. J."},{"key":"B113","doi-asserted-by":"publisher","first-page":"6972","DOI":"10.1523\/JNEUROSCI.4278-06.2007","article-title":"Widespread disruption of repressor element-1 silencing transcription factor\/neuron-restrictive silencer factor occupancy at its target genes in Huntington\u2019s disease","volume":"27","author":"Zuccato","year":"2007","journal-title":"J. Neurosci."}],"container-title":["Frontiers in Molecular Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnmol.2019.00156\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T10:28:50Z","timestamp":1560940130000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnmol.2019.00156\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,19]]},"references-count":108,"alternative-id":["10.3389\/fnmol.2019.00156"],"URL":"https:\/\/doi.org\/10.3389\/fnmol.2019.00156","relation":{},"ISSN":["1662-5099"],"issn-type":[{"value":"1662-5099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,19]]},"article-number":"156"}}